AlphaPeptide
Cart0

AlphaPeptide Technical Profile

Retatrutide Technical Profile: Peptide Identity, Molecular Data, and Research-Use Characterization

A technical overview of Retatrutide covering peptide identity, CAS number, molecular formula, molecular weight, structural design, receptor-pathway research profile, analytical characterization, storage considerations, and research-use compliance boundaries.

Retatrutide Technical Profile: CAS, Molecular Formula, Peptide Identity and Quality Documentation

Core Summary

Retatrutide is a synthetic modified peptide developed for laboratory research involving multi-receptor peptide signaling pathways. It is commonly described as a triple agonist research peptide associated with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathway studies.

From a technical product review perspective, Retatrutide is best evaluated through its peptide identity, molecular composition, structural modification profile, analytical characterization, and batch-specific product data. These parameters help researchers and purchasing teams confirm that the listed material matches the required reference identity for laboratory-use evaluation.

Biochemical Identity and Molecular Profile

Retatrutide is a long-chain synthetic peptide with a modified amino acid sequence and lipidated structural design. Its peptide architecture is used in research settings where investigators compare multi-pathway receptor interaction profiles, sequence modification strategies, and analytical behavior of complex peptide compounds.

Key identity parameters include:

  • Product Name: Retatrutide
  • CAS Number: 2381089-83-2
  • Molecular Formula: C221H342N46O68
  • Molecular Weight: 4731.4 g/mol
  • Peptide Length: 39 amino acids
  • Product Type: Synthetic modified peptide
  • Research Category: Triple agonist peptide research compound
  • Related Pathway Profile: GLP-1, GIP, and glucagon receptor pathway studies
  • Amino Acid Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(γ-Glu-AEEA2-C20diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Because Retatrutide is a structurally complex peptide, the molecular formula and molecular weight should always be checked against the applicable product specification, batch documentation, or supplier-provided analytical records.

Structural Design and Research Relevance

Retatrutide belongs to a class of modified peptide compounds designed to support research into coordinated peptide receptor signaling. Its structural profile is associated with three receptor pathway areas: GLP-1 receptor research, GIP receptor research, and glucagon receptor research.

The peptide’s modified backbone and extended molecular structure make it relevant for technical studies involving peptide stability, receptor-pathway comparison, molecular recognition, and analytical characterization. In research documentation, Retatrutide is usually reviewed as a structurally modified peptide rather than a simple linear peptide.

This type of compound is often evaluated through sequence identity, molecular mass confirmation, chromatographic purity, impurity profile, and batch consistency. These data points are especially important because small differences in peptide sequence, modification site, or salt form may affect how the compound is identified and documented.

Analytical Characterization

For Retatrutide, analytical characterization typically focuses on identity confirmation, purity profile, and consistency between the listed molecular data and the available batch records.

Common analytical review points include:

  • Peptide identity confirmation
  • Molecular weight consistency
  • HPLC purity profile
  • Major peak retention behavior
  • Impurity distribution
  • Water content or moisture-related data
  • Batch number consistency
  • Appearance and physical form
  • Storage condition notes

High-performance liquid chromatography (HPLC) is commonly used to review peptide purity and chromatographic profile. Mass spectrometry may be used to support molecular identity confirmation where available. These methods help verify whether the tested batch is consistent with the expected Retatrutide identity and molecular profile.

Physical Form and Packaging Review

Retatrutide is commonly supplied as a lyophilized peptide powder for laboratory-use handling and product stability review. The physical form, vial format, and packaging configuration should be checked against the specific product page and batch documentation.

Typical product listing fields may include:

  • Physical Form: Lyophilized powder
  • Package Format: 10vial/kits
  • Available Strengths: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
  • Packaging Review: Sealed vial packaging with protective outer packaging
  • Documentation Review: Product specification and batch-level analytical records where available

Packaging information should be treated as product-specific rather than universal. Customers should confirm the current package format and available vial options on the active product page before placing an order.

Storage Considerations

Retatrutide storage requirements should be reviewed according to the applicable product documentation. As with many lyophilized peptide products, storage recommendations may depend on product format, packaging condition, shipping route, and batch-specific documentation.

For technical review purposes, customers should check whether the product page or supporting documentation includes storage condition notes, handling precautions, and shipment-related information. Storage statements should be followed according to the product documentation supplied with the specific batch.

This section is intended for documentation review only and does not provide experimental preparation, reconstitution, dosing, or application instructions.

Research-Use Compliance Boundary

Retatrutide products are supplied for research and laboratory use only. They are not intended for diagnostic, clinical, veterinary, personal, or consumer use.

Customers are responsible for confirming that procurement, importation, possession, handling, storage, and laboratory use comply with applicable local rules, institutional requirements, and jurisdiction-specific regulations.

This article is intended to support product identity review and technical documentation evaluation. It does not provide medical advice, dosage guidance, administration instructions, therapeutic claims, or patient-use information.

Related Internal Links

Reference Sources